Dementia is a leading cause of disability and death worldwide. At present there is no
disease modifying treatment for any of the most common types of dementia such as …

Alzheimer's disease (AD) is the most common chronic disease in the elderly, with a high
incidence rate. In recent years, deep learning has become popular in the field of medical …

Background: Alzheimer's disease (AD) is a complex and severe neurodegenerative disease
that still lacks effective methods of diagnosis. The current diagnostic methods of AD rely on …

Abstract Background & Objective With populations aging, the number of people with
dementia worldwide is expected to triple to 152 million by 2050. Seventy percent of cases …

Alzheimer's disease (AD) is an irreversible, progressive brain disorder that slowly destroys
memory and thinking skills. It is one of the leading types of dementia for persons aged above …

Exploring individual brain atrophy patterns is of great value in precision medicine for
Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, the current …

Alzheimer's disease (AD) presents a significant challenge in neurodegenerative research
and clinical practice due to its complex etiology and progressive nature. The integration of …

Identification of Alzheimer's disease (AD) onset risk can facilitate interventions before
irreversible disease progression. We demonstrate that electronic health records from the …

Background Alzheimer's disease, the most common cause of dementia, causes a
progressive and irreversible deterioration of cognition that can sometimes be difficult to …

Introduction Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Current
core cerebrospinal fluid (CSF) AD biomarkers, widely employed for diagnosis, require a …